How BMI OrganBank Is Changing the Kidney Transplant Equation

Article by Innovation Quarter

In a lesser-recognized pocket of the Innovation Quarter, there’s a knot of research buildings forming one of the world’s foremost hubs of regenerative medicine. Here, both academic and commercial parties have formed a neighborhood of regenerative medicine—research that focuses on healing or restoring tissue damaged by illness, age, or injury. These organizations collaborate and support each other, anchored by Wake Forest Institute of Regenerative Medicine (WFIRM), one of the most widely recognized leaders in regenerative medicine research.

One of these buildings is home to an innovation accelerator run by the RegenMed Development Organization (ReMDO), a non-profit dedicated to promoting regenerative medicine. The accelerator comprises an incubation space for biotech companies and down one long hall, you’ll find offices and wet lab space for companies doing some unbelievable things.

Nestled among startups studying the aging of stem cells in space (Axiom Space) and 3D printing live cells (Brinter), you’ll find a company that’s revolutionizing the landscape of organ preservation: BMI OrganBank.